Across North America, increasing diabetes prevalence and growing demand for efficient glycemic monitoring solutions are supporting the adoption of glycated albumin testing. The ability of glycated albumin assays to evaluate blood glucose control over a shorter period than conventional long-term biomarkers makes them valuable for monitoring recent treatment responses and changes in glucose...